Patent expiries already hitting Pfizer profits
Generic competition is already hurting Pfizer's global profits, with results for the fourth quarter of 2011 showing a 24 per cent decline in revenue from Lipitor alone.
2 days ago0
Switching to generic statins may increase cardiovascular event risk: study
Switching from Lipitor to generic simvastatin may lead to less potent doses being used and potentially increase the risk of cardiovascular events, new research suggests.
3 weeks ago0
Pfizer quiet on Lipitor rescheduling claims
Pfizer is remaining tight-lipped in the wake of reports the company is seeking to have blockbuster drug Lipitor (atorvastatin) rescheduled...
Pfizer to launch new Lipitor tablet
The size and shape of the blockbuster statin, Lipitor (atorvastatin) will become smaller in every way this June, but each...
Clear and concise CMI needed
Patients want information about medicines to be straightforward, a new report reveals.
Generics hinging on generational change
A generation chasm within community pharmacy needs to be bridged before generic substitutions take a greater hold in the sector, the head of one of the main generic manufacturers has warned.
2 years ago0
Browse our newsletter archive
Advertisement